Evaluating Human Papillomavirus Vaccination Programs

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated vaccination programs with a vaccine against HPV-16 and HPV-18. We developed disease transmission models that estimated...

Description complète

Détails bibliographiques
Auteurs principaux: Al V. Taira, Christopher P. Neukermans, Gillian D. Sanders
Format: Article
Langue:English
Publié: Centers for Disease Control and Prevention 2004-11-01
Collection:Emerging Infectious Diseases
Sujets:
Accès en ligne:https://wwwnc.cdc.gov/eid/article/10/11/04-0222_article